Skip to main content

Table 5 Serum FST levels in patients with LADC according to TNM staging

From: Association of serum follistatin levels with histological types and progression of tumor in human lung cancer

 

n

Mean ± SD, pg/mL

Minimum–maximum, pg/mL

Healthy subjects

37

760.09 ± 115.65

570.88–1170.24

Benign diseases

22

1225.60 ± 323.40#

608.36–1763.76

LADC

33

  

 I

14

1404.69 ± 245.02#

877.29–1900.14

 II

5

1409.18 ± 199.51#

1150.05–1763.76

III

7

1578.68 ± 276.90#*

1150.05–2104.71

IV

7

1802.73 ± 311.12#**S

1150.05–2241.09

  1. #P < 0.01 compared with the healthy group; * P < 0.05, ** P < 0.01, compared with benign disease group; SP < 0.05, compared with I and II stage group
Back to article page

Cancer Cell International

ISSN: 1475-2867

Contact us